|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Complex Genetics Section, DBG-Dept. of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
2 Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands
3 Paediatrics, Paediatrician Unit of Paediatric Gastroenterology, Leiden University Medical Centre, Leiden, The Netherlands
* To whom correspondence should be addressed. E-mail: t.n.wijmenga{at}med.uu.nl.
Celiac disease (CD) is a complex genetic disorder of the small intestine. The DQ2/DQ8 HLA genes explain approximately 40% of the genetic component of the disease, but the remaining non-HLA genes have not yet been identified. The key environmental factor known to be involved in the disease is gluten, a major protein present in wheat, barley and rye. Integrating microarray data and linkage data from chromosome 6q21-22 revealed the prolyl endopeptidase (PREP) gene as a potential CD candidate in the Dutch population. Interestingly, this gene encodes for the only enzyme that is able to cleave the proline rich gluten peptides. To investigate the role of the human PREP gene as a primary genetic factor in CD,we conducted gene expression, sequence analysis and genetic association studies of the PREP gene and determined PREP enzyme activity in biopsies from CD patients and controls. Sequence analysis of the coding region of the PREP gene revealed two novel polymorphisms. Genetic association studies using two novel polymorphisms and three known PREP variants excluded a genetic association between PREP and CD. Determination of PREP activity revealed weak but significant differences between treated and untreated CD biopsies (p< 0.05). Our results from the association study indicate that PREP is not a causative gene for CD in the Dutch population. These are further supported by the activity determinations in which we observed no differences in PREP activity between CD patients and controls.
This article has been cited by other articles:
![]() |
N. Cerf-Bensussan, T. Matysiak-Budnik, C. Cellier, and M. Heyman Oral proteases: a new approach to managing coeliac disease Gut, February 1, 2007; 56(2): 157 - 160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |